D-cycloserine

D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.

Cross Reference

Introduction

To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with D-cycloserine?

D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with D-cycloserine

MeSH term MeSH ID Detail
Starvation D013217 47 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with D-cycloserine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with D-cycloserine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with D-cycloserine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with D-cycloserine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with D-cycloserine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with D-cycloserine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with D-cycloserine

Download all related citations
Per page 10 20 50 100 | Total 2271
Authors Title Published Journal PubMed Link
Li C et al. [A preliminary study on the molecular characteristics of D-cycloserine resistance of ]. 2017 Zhonghua Liu Xing Bing Xue Za Zhi pmid:28231674
Zhuang YH [Studies on the induction of the L-form in Mycobacteria]. 1984 Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi pmid:6443303
Radakova ED and Androsov VV [Genetic characteristics of E. coli K-12 spheroplasts]. 1971 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:4943711
Zykov MP [Correlation between the catalase activity and resistance to drugs in Mycobacterium tuberculosis circulating in Southeast Africa]. 1966 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:4295172
Dorozhkova IR and Volk AV [Phases of morphogenesis of L forms of Mycobacterium tuberculosis, developing on exposure to antibiotics and tuberculostatic agents]. 1973 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:4131407
Sivov IG et al. [The effect of penicillin on lon-negative mutants of E. coli K-12]. 1974 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:4375923
RAZUMOVA IL [Effect of a brief series of therapeutic doses of d-cycloserine on the conditioned reflex activity in the rat]. 1962 Mar-Apr Zh Vyssh Nerv Deiat Im I P Pavlova pmid:14490770
RAZUMOVA IL [COMPARATIVE STUDY OF THE FUNCTIONAL AND MORPHOLOGICAL CHANGES IN THE CENTRAL NERVOUS SYSTEM OF WHITE RATS FOLLOWING INTERMITTENT ADMINISTRATION OF DL-CYCLOSERINE]. 1964 Nov-Dec Zh Vyssh Nerv Deiat Im I P Pavlova pmid:14337353
RAZUMOVA IL [Comparative study of functional and morphological changes under the action of dl-cycloserine on the central nervous system]. 1963 Mar-Apr Zh Vyssh Nerv Deiat Im I P Pavlova pmid:13973367
KUTSENOK BM [PSYCHIC DISORDERS DURING CYCLOSERINE THERAPY OF PULMONARY TUBERCULOSIS]. 1964 Zh Nevropatol Psikhiatr Im S S Korsakova pmid:14328187
KOROL II [PSYCHIC DISORDERS IN CYCLOSERINE THERAPY OF PULMONARY TUBERCULOSIS]. 1964 Zh Nevropatol Psikhiatr Im S S Korsakova pmid:14328188
Gubash SM and Ingham L Comparison of a new, bismuth-iron-sulfite-cycloserine agar for isolation of Clostridium perfringens with the tryptose-sulfite-cycloserine and blood agars. 1997 Zentralbl. Bakteriol. pmid:9084113
Rastogi N et al. Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs? 1992 Zentralbl. Bakteriol. pmid:1303690
Mossel DA and Pouw H Studies on the suitability of sulphite cycloserine agar for the enumeration of clostridium perfringens in food and water. 1973 Zentralbl Bakteriol Orig A pmid:4146832
Abdou MA [Synthetic medium for testing of susceptibility. I. Susceptibility of bacteria to antibiotics and chemotherapeutic agents (author's transl)]. 1974 Zentralbl Bakteriol Orig A pmid:4155867
Giesbrecht P [Several reactions of "eukaryotic" cells upon substances which in "prokaryotic" cells lead to changes in the cell wall]. 1964 Zentralbl Bakteriol Orig pmid:5831633
PLAPP R [ACTIVITY OF ALANINE RACEMASE IN PROTEUS, IN THE L-PHASE AND IN PLEUROPNEUMONIA-LIKE ORGANISMS (PPLO)]. 1963 Zentralbl Bakteriol Orig pmid:14119936
FIRSOVA LP [CYCLOSERINE THERAPY OF PATIENTS WITH PULMONARY TUBERCULOSIS]. 1963 Zdravookhr Beloruss pmid:14064746
Plapp R and Kandler O [Amino acid sequence of the aspartic acid-containing murein from Lactobacillus coryniformis and Lactobacillus cellobinosus]. 1967 Z. Naturforsch. B pmid:4385823
Iwainsky H et al. [Studies on the endogenous metabolism of mycobacteria. 2. On the influence of enzyme inhibitors and effective antitubercular substances on 32 P-incorporation]. 1968 Z. Naturforsch. B pmid:4385975
Gause GF et al. Mutants with altered DNA base composition in Bacterium paracoli--the evidence from a marker. 1971 Z. Allg. Mikrobiol. pmid:5563616
Strauss I [Tuberculostatic tolerance of a tuberculous kidney]. 1969 Z Urol Nephrol pmid:4325816
HASCHEK H [D-Cycloserine: indications for use in urology]. 1961 Z Urol pmid:13712086
Bönicke R [Current status of the classification of atypical mycobacteria by biochemical methods]. 1967 Z Tuberk Erkr Thoraxorg pmid:4970617
Canetti G [Bacterial resistance and its relation to chemotherapy]. 1968 Z Tuberk Erkr Thoraxorg pmid:4973008
Schmiedel A [On the variability of results of sensitivity determination in tuberculosis bacteria]. 1968 Z Tuberk Erkr Thoraxorg pmid:4973009
WERNER E et al. [D-CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS. (ARE TUBERCULOSTATICS OF THE 2D GROUP NECESSARY?]. 1964 Z Tuberk Erkr Thoraxorg pmid:14141370
Frankl J and Vázsonyi Z [Contributions to dermatological use of cycloserine]. 1965 Z Tuberk Erkr Thoraxorg pmid:5899094
Grunert M et al. [On qualitative demonstration of tuberculostatics in the control of taking of drugs]. 1965 Z Tuberk Erkr Thoraxorg pmid:5899136
Dümchen F and Ulber H [Mycobacterium fortuitum as a cause of a bilateral tuberculosis-like lung disease associated with a mega-esophagus]. 1965 Z Tuberk Erkr Thoraxorg pmid:5899165
Schumann C [Unmotivated suicide as a most serious complication in the treatment of pulmonary tuberculosis using D-cycloserine]. 1968 Z Tuberk Erkr Thoraxorg pmid:5756628
Hejný J and Hejná A [The secondary sensitivity of mycobacteria]. 1967 Z Tuberk Erkr Thoraxorg pmid:4299812
Iwainsky H et al. [On the fate of tuberculostatics in macro- and microorganisms]. 1967 Z Tuberk Erkr Thoraxorg pmid:4876797
Vloet TD et al. [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder]. 2012 Z Kinder Jugendpsychiatr Psychother pmid:22161940
Kühn RA et al. [Clinical problems of the syntropy of pulmonary tuberculosis and stomach resection]. 1971 Z Gesamte Inn Med pmid:5565822
Vieritz HD [The abdominal tuberculoses]. 1978 Z Gesamte Inn Med pmid:216170
Bosseckert H et al. [Influence of various antitubercular agents on the xylose resorption test]. 1971 Z Gesamte Inn Med pmid:5141037
Ballin A and Otto BS [Perthoracal local therapy of cavernous silicotuberculosis]. 1970 Z Erkr Atmungsorgane Folia Bronchol pmid:5002291
Anastasatu C et al. [Rheumatic diseases caused by antitubercular drugs]. 1972 Z Erkr Atmungsorgane Folia Bronchol pmid:4538033
Wehrheim W [Urotuberculosis and genitaltuberculosis in the male (UGT)]. 1969 Z Erkr Atmungsorgane Folia Bronchol pmid:4983807
Neef W [Endocavernous treatment of caverns with atypical Mycobacteria]. 1970 Z Erkr Atmungsorgane Folia Bronchol pmid:5210837
Zierski M [Late results in the treatment of chronic resistant pulmonary tuberculosis with tuberculostatics of the 2d series]. 1970 Z Erkr Atmungsorgane Folia Bronchol pmid:5204739
Eule H [Current status of chemotherapy of pulmonary tuberculosis and its further prospectives]. 1971 Z Erkr Atmungsorgane Folia Bronchol pmid:4934592
Krebs A [Experimental chemotherapy of tuberculosis]. 1969 Z Erkr Atmungsorgane Folia Bronchol pmid:4899157
Schuh D et al. [Incidence of drug sensitivity decrease in tuberculosis bacteria in untreated tuberculoses using autopsy material]. 1974 Z Erkr Atmungsorgane pmid:4212675
STEINBRUECK P and ZAUMSEIL I [The treatment of pulmonary tuberculosis with the drugs of the 2d series (Aetina, d-cycloserine and pyrazinamide) with special reference to experiences with Aetina]. 1962 Z Arztl Fortbild (Jena) pmid:13916698
Lee SH et al. Sequential bilateral lung resection in a patient with Mycobacterium abscessus lung disease refractory to medical treatment. 2010 Yonsei Med. J. pmid:20046529
Kim HC et al. Endobronchial tuberculosis presenting as right middle lobe syndrome: clinical characteristics and bronchoscopic findings in 22 cases. 2008 Yonsei Med. J. pmid:18729304
Lee SH et al. Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB. 2015 Yonsei Med. J. pmid:26069117
NAGASAWA J [CONSERVATIVE TREATMENT OF PULMONARY TUBERCULOSIS DIFFICULT TO CURE IN ELDERLY PATIENTS UNFIT FOR SURGERY]. 1963 Yokufuen Chosa Kenkyu Kiyo pmid:14134982
Sighart H and Opl G [Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)]. 1969 Wien. Klin. Wochenschr. pmid:5380791
HURNI H [On new tuberculostatic agents]. 1963 Wien. Klin. Wochenschr. pmid:13955854
Daddi G [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin]. 1967 Wien Med Wochenschr pmid:5626324
Zierski M [Experiences with antitubercular agents of the second line]. 1966 Wien Med Wochenschr pmid:5927179
BUTT H [A clinical experience report on combined therapy of pulmonary tuberculosis with cycloserine-pyrazinamide]. 1961 Wien Med Wochenschr pmid:13689455
Freerksen E [Experimental therapy with so-called "minor" tuberculostatics]. 1966 Wien Med Wochenschr pmid:6005730
Wewalka G et al. [Comparative studies in vitro on the antibiotic effectiveness of Terizidon]. 1974 Wien Med Wochenschr pmid:4207337
Neumann G [Duration of the after-control of the tuberculous patients following the termination of the treatment]. 1972 Wien Med Wochenschr pmid:4346497
PICHA E [Treatment of infections of the excretory urinary tract with D-cycloserine]. 1959 Wien Med Wochenschr pmid:14432724
Glowacka M and Kostrubala M [Cycloserine in treatment of children]. 1966 Wiad. Lek. pmid:5296694
Popkowska N [Anxiety-paranoic psychosis in the course of treatment with cycloserine]. 1966 Wiad. Lek. pmid:5942928
Kochnowski G [Therapy of pulmonary tuberculosis with reserve drugs in the light of our personal observations]. 1970 Wiad. Lek. pmid:4312765
KHOMUTOV RM et al. [On some analogs of cycloserine with antitubercular effect]. 1962 Jul-Aug Vopr. Med. Khim. pmid:14032397
Marveeva AA et al. [Effect of the antibiotic D-cycloserine and its dimer on the activity of tyrosine aminotransferase in liver tissue of intact, adrenalectomized and hypophysectomized rats]. 1975 May-Jun Vopr. Med. Khim. pmid:1901
PASKHINA Ts [EFFECT OF CYCLOSERINE ISOMERS ON THE ACTIVITY OF D-ALANINE-D-GLUTAMATE-TRANSAMINASE IN BAC. SUBTILIS]. 1964 Sep-Oct Vopr. Med. Khim. pmid:14297238
Bukin IuV and Lukienko EP [Effect of methylglyoxal bis(guanylhydrazone) in combination with antifolic acid preparations on the biochemical indices and growth of Pliss lymphosarcoma in rats]. 1986 Vopr Onkol pmid:3754363
Fitzgerald SD et al. Antimicrobial Susceptibility Testing of Mycobacterium bovis Isolates from Michigan White-Tailed Deer during the 2009 Hunting Season. 2010 Vet Med Int pmid:21151656
Bukin IuV et al. [New route of regulating folic acid metabolism in experimental chemotherapy of leukoses and malignant neoplasms]. 1971 Vestn. Akad. Med. Nauk SSSR pmid:4326180
Strong DW et al. Renal tuberculosis simulating polycystic kidney disease angiographically. 1974 Urology pmid:4836341
König K [Drug therapy of urogenital tuberculosis]. 1970 Urologe pmid:5461516
König K and May P [The treatment of urogenital tuberculosis with current drugs]. 1968 Jan-Feb Urologe pmid:4297580
ALBRECHT KF [UROGENITAL TUBERCULOSIS: PATHOGENESIS, DIAGNOSIS AND THERAPY. SURVEY OF THE MOST IMPORTANT PUBLICATIONS OF THE LAST YEARS]. 1964 Urologe pmid:14160920
Koukol SC et al. Drug therapy of bacillus Calmette-Guérin sepsis. 1995 Urol. Res. pmid:7740657
Berktin K [Minor tuberculostatic drugs]. 1967 Turk Tip Cemiy Mecm pmid:4300575
CHAULET P [Focal epilepsy and cycloserine: an anatomoclinical observation]. 1960 Sep-Oct Tunis Med pmid:13692662
Bartal M et al. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)]. 1973 Tunis Med pmid:4209977
KENEZ J and SZASZI E [Experiences with cycloserine therapy]. 1960 Tuberkulozis pmid:14408491
SZASZ V [Observations on 39 patients treated with cycloserine]. 1960 Tuberkulozis pmid:13774496
LOW B et al. [Cycloserine: a new antibiotic for the treatment of tuberculosis]. 1959 Tuberkulozis pmid:14418512
GIUNIO N [Combined therapy with tuberculostatics of the 2d group of resistant patients]. 1962 Jan-Mar Tuberkuloza pmid:13948283
PETKOVIC S [A CHEMICAL METHOD FOR THE QUANTITATIVE DETERMINATION OF SOME TUBERCULOSTATICS IN THE SPUTUM]. 1963 Apr-Jun Tuberkuloza pmid:14067283
PRIMER G [Cycloserine therapy in childhood and adolescence]. 1960 Tuberkulosearzt pmid:14434908
ISEBARTH R and WIEDEMANN O [D-cycloserine in pulmonary tuberculosis. Report on a collective study from 9 hospitals]. 1960 Tuberkulosearzt pmid:14405880
SCHULTKA H [D-cycloserine in tuberculous patients with simultaneously existing psychiatric-neurological disease]. 1961 Tuberkulosearzt pmid:13748849
NASSAL J and PETERSEN KF [Result of sensitivity evaluation of human, bovine and avian tuberculosis bacteria]. 1961 Tuberkulosearzt pmid:14478466
Nix DE et al. Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid. 2004 Tuberculosis (Edinb) pmid:15525560
Cycloserine. 2008 Tuberculosis (Edinb) pmid:18486041
Donald PR The chemotherapy of tuberculous meningitis in children and adults. 2010 Tuberculosis (Edinb) pmid:20810322
Donald PR Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. 2010 Tuberculosis (Edinb) pmid:20709598
Nageswara Rao KV et al. Sodium nitroprusside test for the detection of isoniazid and acetylisoniazid in urine. 1967 Tubercle pmid:4166512
Intermittent chemotherapy. 1967 Tubercle pmid:4166513
Dickinson JM and Mitchison DA In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens. 1968 Tubercle pmid:4173333
Tuberculosis Chemotherapy Centre, Madras. 1968 Tubercle pmid:4173465
Dickinson JM and Mitchison DA Activity of the combination of fludalanine and cycloserine against mycobacteria in vitro. 1985 Tubercle pmid:4024268
International conference. 1967 Tubercle pmid:5588949
Stott H Deterioration of cycloserine in the tropics. 1968 Tubercle pmid:5659248
Tousek J et al. The results of treatment in patients with cultures resistant to streptomycin, isoniazid and PAS: a five-year follow-up. 1967 Tubercle pmid:4291925
Clark J and Wallace A The susceptibility of mycobacteria to rifamide and rifampicin. 1967 Tubercle pmid:4293697
Swash M et al. Reversible pellagra-like encephalopathy with ethionamide and cycloserine. 1972 Tubercle pmid:4261138
KRAUS P et al. A paper strip test for detection of cycloserine and pyrazinamide in urine. 1961 Tubercle pmid:14459415